• No results found

Assessment of bone marrow derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial

N/A
N/A
Protected

Academic year: 2020

Share "Assessment of bone marrow derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig. 1 Study schema for the ACTiMuS trial
Table 1 Eligibility criteria for the ACTiMuS trial

References

Related documents

Protective effect of single or combined treatment of Moringa oleifera and Citrullus colocynthis on carbon tetrachloride induced hematological and cardiac toxicity

Figure 4: Tonic GABAergic current is not affected by MPH treatment. B) The baseline current recorded in the first five minutes in the presence of DNQX and APV is not affected by

However, due to lack of appropriate planning and structured formal systems for converting, maintain- ing, and transferring information and knowledge regarding health, it can be

It was shown by the second author that for n = 2, solvable groups which contain the binary adding machine are conjugate to some subgroups of Γ i acting on the binary

There seems to be a lack in the literature to establish the effectiveness of MET when compared to ischemic compression and therapeutic ultrasound in the treatment

The enzymes implicated in lignin degradation are: lignin peroxidase (catalyses the oxidation of both phenolic and non-phenolic units), manganese-dependent peroxidase, (iii) laccase

2 Prevalence of non-alcoholic fatty liver disease (NAFLD) in relation to thyroid function in the present study.. The figure plots